MIR3686

Across TCGA pan-cancer cohorts, MIR3686 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR3686 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher MIR3686 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3686 expression acts as an unfavorable survival marker.

PAAD, CHOL, and ESCA are the cancer types where MIR3686 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.110	0.640	<.001	72	view →
CHOL	OS	Tertile	All	0.019	0.800	<.001	72	view →
ESCA	OS	Tertile	II,III,IV	0.277	0.707	.004	72	view →
HNSC	OS	Tertile	All	0.139	0.687	.001	36	view →
STAD	DFS	Tertile	II,III,IV	0.164	0.525	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR3686–PAAD (OS)

Open the PAAD breakdown →